Showing results (221-230 of 413) with videos related to

Sort By:
Pageof 42
Oncotarget|May 1, 2017
Predictive blood plasma biomarkers for EGFR inhibitor-induced skin rashVivien Hichert, Catharina Scholl, Michael Steffens, et al.
Journal of Molecular Medicine (Berlin, Germany)|October 31, 2025
Peptide-based inhibition of CD44v6 renders liver carcinomas more susceptible to therapeutic interventionAkshaya Srikanth, Ranjitha Vishnu Anand Rao, Rui Dong, et al.
Journal of Cellular and Molecular Medicine|March 11, 2015
IGF-1 drives chromogranin A secretion via activation of Arf1 in human neuroendocrine tumour cellsChristin Münzberg, Katharina Höhn, Denis Krndija, et al.
Zeitschrift Fur Gerontologie Und Geriatrie|July 14, 2021
[COVID-19 pandemic-related burden and SARS-CoV-2 prevalence in care facilities]Lukas Perkhofer, Peter Grünke, Edonjeta Gashi-Ymeri, et al.
European Journal of Cancer (Oxford, England : 1990)|May 27, 2014
Cytokine regulation by epidermal growth factor receptor inhibitors and epidermal growth factor receptor inhibitor associated skin toxicity in cancer patientsTanusree Paul, Christian Schumann, Stefan Rüdiger, et al.
United European Gastroenterology Journal|August 18, 2025
Homologous Repair-Deficient Pancreatic Cancer: Refined Targeting of DNA Damage Response is an Effective Therapeutic StrategyAlica K Beutel, Christopher J Halbrook, Menar Ekizce, et al.
Journal of Clinical Medicine|June 13, 2020
Adverse Drug Reactions in the Emergency Department: Is There a Role for Pharmacogenomic Profiles at Risk?-Results from the ADRED StudyKatja S Just, Harald Dormann, Marlen Schurig, et al.
Pageof 42